LifeMD, Inc. (LFMDP) Stock Competitors & Peer Comparison
See (LFMDP) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LFMDP | $23.35 | +0.11% | 158.6M | 287.80 | $0.08 | N/A |
| RPRX | $57.30 | -1.51% | 24.6B | 11.30 | $5.07 | +1.57% |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| CORT | $91.57 | +1.16% | 9.8B | 261.54 | $0.35 | N/A |
| LQDA | $77.08 | -3.58% | 6.9B | 550.57 | $0.14 | N/A |
| KNSA | $62.58 | -2.14% | 4.7B | 69.53 | $0.90 | N/A |
| VCRE | $11.44 | -3.21% | 3.4B | N/A | N/A | N/A |
| TRLV | $8.76 | -0.34% | 1.5B | -20.94 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
Stock Comparison
LFMDP vs RPRX Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, RPRX has a market cap of 24.6B. Regarding current trading prices, LFMDP is priced at $23.35, while RPRX trades at $57.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas RPRX's P/E ratio is 11.30. In terms of profitability, LFMDP's ROE is -1.72%, compared to RPRX's ROE of +0.13%. Regarding short-term risk, LFMDP is less volatile compared to RPRX. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check RPRX's competition here
LFMDP vs WBA Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, LFMDP is priced at $23.35, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas WBA's P/E ratio is -1.64. In terms of profitability, LFMDP's ROE is -1.72%, compared to WBA's ROE of -0.42%. Regarding short-term risk, LFMDP and WBA have similar daily volatility (0.00).Check WBA's competition here
LFMDP vs CORT Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, CORT has a market cap of 9.8B. Regarding current trading prices, LFMDP is priced at $23.35, while CORT trades at $91.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas CORT's P/E ratio is 261.54. In terms of profitability, LFMDP's ROE is -1.72%, compared to CORT's ROE of +0.08%. Regarding short-term risk, LFMDP is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check CORT's competition here
LFMDP vs LQDA Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, LQDA has a market cap of 6.9B. Regarding current trading prices, LFMDP is priced at $23.35, while LQDA trades at $77.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas LQDA's P/E ratio is 550.57. In terms of profitability, LFMDP's ROE is -1.72%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, LFMDP is less volatile compared to LQDA. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check LQDA's competition here
LFMDP vs KNSA Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, KNSA has a market cap of 4.7B. Regarding current trading prices, LFMDP is priced at $23.35, while KNSA trades at $62.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas KNSA's P/E ratio is 69.53. In terms of profitability, LFMDP's ROE is -1.72%, compared to KNSA's ROE of +0.13%. Regarding short-term risk, LFMDP is less volatile compared to KNSA. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check KNSA's competition here
LFMDP vs VCRE Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, VCRE has a market cap of 3.4B. Regarding current trading prices, LFMDP is priced at $23.35, while VCRE trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas VCRE's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.72%, compared to VCRE's ROE of N/A. Regarding short-term risk, LFMDP is less volatile compared to VCRE. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check VCRE's competition here
LFMDP vs TRLV Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, TRLV has a market cap of 1.5B. Regarding current trading prices, LFMDP is priced at $23.35, while TRLV trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas TRLV's P/E ratio is -20.94. In terms of profitability, LFMDP's ROE is -1.72%, compared to TRLV's ROE of -0.07%. Regarding short-term risk, LFMDP is less volatile compared to TRLV. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check TRLV's competition here
LFMDP vs HROWL Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, LFMDP is priced at $23.35, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas HROWL's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.72%, compared to HROWL's ROE of -0.34%. Regarding short-term risk, LFMDP is less volatile compared to HROWL. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check HROWL's competition here
LFMDP vs HROWM Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, LFMDP is priced at $23.35, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas HROWM's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.72%, compared to HROWM's ROE of -0.34%. Regarding short-term risk, LFMDP is less volatile compared to HROWM. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check HROWM's competition here
LFMDP vs AVLN Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, AVLN has a market cap of 1.3B. Regarding current trading prices, LFMDP is priced at $23.35, while AVLN trades at $28.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas AVLN's P/E ratio is -1.31. In terms of profitability, LFMDP's ROE is -1.72%, compared to AVLN's ROE of +0.36%. Regarding short-term risk, LFMDP is less volatile compared to AVLN. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check AVLN's competition here
LFMDP vs CGEM Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, CGEM has a market cap of 1.1B. Regarding current trading prices, LFMDP is priced at $23.35, while CGEM trades at $17.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas CGEM's P/E ratio is -5.21. In terms of profitability, LFMDP's ROE is -1.72%, compared to CGEM's ROE of -0.51%. Regarding short-term risk, LFMDP is less volatile compared to CGEM. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check CGEM's competition here
LFMDP vs TBPH Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, TBPH has a market cap of 871.2M. Regarding current trading prices, LFMDP is priced at $23.35, while TBPH trades at $16.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas TBPH's P/E ratio is -220.60. In terms of profitability, LFMDP's ROE is -1.72%, compared to TBPH's ROE of +0.44%. Regarding short-term risk, LFMDP is less volatile compared to TBPH. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check TBPH's competition here
LFMDP vs XOMAP Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, XOMAP has a market cap of 301.3M. Regarding current trading prices, LFMDP is priced at $23.35, while XOMAP trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas XOMAP's P/E ratio is 13.72. In terms of profitability, LFMDP's ROE is -1.72%, compared to XOMAP's ROE of +0.32%. Regarding short-term risk, LFMDP and XOMAP have similar daily volatility (0.00).Check XOMAP's competition here
LFMDP vs IKT Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, IKT has a market cap of 294.4M. Regarding current trading prices, LFMDP is priced at $23.35, while IKT trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas IKT's P/E ratio is -5.19. In terms of profitability, LFMDP's ROE is -1.72%, compared to IKT's ROE of -0.41%. Regarding short-term risk, LFMDP is less volatile compared to IKT. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check IKT's competition here
LFMDP vs LFMD Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, LFMD has a market cap of 208.9M. Regarding current trading prices, LFMDP is priced at $23.35, while LFMD trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas LFMD's P/E ratio is -11.17. In terms of profitability, LFMDP's ROE is -1.72%, compared to LFMD's ROE of -1.72%. Regarding short-term risk, LFMDP is less volatile compared to LFMD. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check LFMD's competition here
LFMDP vs HITI Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, HITI has a market cap of 189.8M. Regarding current trading prices, LFMDP is priced at $23.35, while HITI trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas HITI's P/E ratio is 54.00. In terms of profitability, LFMDP's ROE is -1.72%, compared to HITI's ROE of -0.43%. Regarding short-term risk, LFMDP is less volatile compared to HITI. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check HITI's competition here
LFMDP vs CIRC Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, CIRC has a market cap of 69.1M. Regarding current trading prices, LFMDP is priced at $23.35, while CIRC trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas CIRC's P/E ratio is -1.75. In terms of profitability, LFMDP's ROE is -1.72%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, LFMDP is less volatile compared to CIRC. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check CIRC's competition here
LFMDP vs PETS Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, PETS has a market cap of 41.9M. Regarding current trading prices, LFMDP is priced at $23.35, while PETS trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas PETS's P/E ratio is -1.85. In terms of profitability, LFMDP's ROE is -1.72%, compared to PETS's ROE of -1.47%. Regarding short-term risk, LFMDP is less volatile compared to PETS. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check PETS's competition here
LFMDP vs RAD Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, LFMDP is priced at $23.35, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas RAD's P/E ratio is -0.05. In terms of profitability, LFMDP's ROE is -1.72%, compared to RAD's ROE of +2.76%. Regarding short-term risk, LFMDP is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check RAD's competition here
LFMDP vs GLTO Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, LFMDP is priced at $23.35, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas GLTO's P/E ratio is -1.78. In terms of profitability, LFMDP's ROE is -1.72%, compared to GLTO's ROE of -1.22%. Regarding short-term risk, LFMDP is less volatile compared to GLTO. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check GLTO's competition here
LFMDP vs SDEV Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, SDEV has a market cap of 33.8M. Regarding current trading prices, LFMDP is priced at $23.35, while SDEV trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas SDEV's P/E ratio is -0.22. In terms of profitability, LFMDP's ROE is -1.72%, compared to SDEV's ROE of +17.15%. Regarding short-term risk, LFMDP is less volatile compared to SDEV. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check SDEV's competition here
LFMDP vs KYNB Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, KYNB has a market cap of 28.7M. Regarding current trading prices, LFMDP is priced at $23.35, while KYNB trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas KYNB's P/E ratio is -0.57. In terms of profitability, LFMDP's ROE is -1.72%, compared to KYNB's ROE of -2.34%. Regarding short-term risk, LFMDP is less volatile compared to KYNB. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check KYNB's competition here
LFMDP vs NSRX Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, NSRX has a market cap of 25.9M. Regarding current trading prices, LFMDP is priced at $23.35, while NSRX trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas NSRX's P/E ratio is -4.18. In terms of profitability, LFMDP's ROE is -1.72%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, LFMDP is less volatile compared to NSRX. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check NSRX's competition here
LFMDP vs SCYX Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, SCYX has a market cap of 24.5M. Regarding current trading prices, LFMDP is priced at $23.35, while SCYX trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas SCYX's P/E ratio is -1.14. In terms of profitability, LFMDP's ROE is -1.72%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, LFMDP is less volatile compared to SCYX. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check SCYX's competition here
LFMDP vs RNTX Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, RNTX has a market cap of 23.6M. Regarding current trading prices, LFMDP is priced at $23.35, while RNTX trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas RNTX's P/E ratio is -0.48. In terms of profitability, LFMDP's ROE is -1.72%, compared to RNTX's ROE of -2.58%. Regarding short-term risk, LFMDP is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check RNTX's competition here
LFMDP vs BFRI Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, BFRI has a market cap of 13.4M. Regarding current trading prices, LFMDP is priced at $23.35, while BFRI trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas BFRI's P/E ratio is -0.98. In terms of profitability, LFMDP's ROE is -1.72%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, LFMDP is less volatile compared to BFRI. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check BFRI's competition here
LFMDP vs MEDS Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, MEDS has a market cap of 13.3M. Regarding current trading prices, LFMDP is priced at $23.35, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas MEDS's P/E ratio is -0.31. In terms of profitability, LFMDP's ROE is -1.72%, compared to MEDS's ROE of -1.21%. Regarding short-term risk, LFMDP is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check MEDS's competition here
LFMDP vs MSLE Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, MSLE has a market cap of 10.8M. Regarding current trading prices, LFMDP is priced at $23.35, while MSLE trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas MSLE's P/E ratio is -6.13. In terms of profitability, LFMDP's ROE is -1.72%, compared to MSLE's ROE of -0.67%. Regarding short-term risk, LFMDP is less volatile compared to MSLE. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check MSLE's competition here
LFMDP vs CJJD Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, LFMDP is priced at $23.35, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas CJJD's P/E ratio is -0.46. In terms of profitability, LFMDP's ROE is -1.72%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, LFMDP is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check CJJD's competition here
LFMDP vs SSY Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, LFMDP is priced at $23.35, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas SSY's P/E ratio is -2.86. In terms of profitability, LFMDP's ROE is -1.72%, compared to SSY's ROE of -0.09%. Regarding short-term risk, LFMDP is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check SSY's competition here
LFMDP vs POM Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, POM has a market cap of 5.8M. Regarding current trading prices, LFMDP is priced at $23.35, while POM trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas POM's P/E ratio is -0.17. In terms of profitability, LFMDP's ROE is -1.72%, compared to POM's ROE of +0.16%. Regarding short-term risk, LFMDP is less volatile compared to POM. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check POM's competition here
LFMDP vs HKPD Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, HKPD has a market cap of 4.3M. Regarding current trading prices, LFMDP is priced at $23.35, while HKPD trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas HKPD's P/E ratio is -6.51. In terms of profitability, LFMDP's ROE is -1.72%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, LFMDP is less volatile compared to HKPD. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check HKPD's competition here
LFMDP vs PAVS Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, PAVS has a market cap of 3.5M. Regarding current trading prices, LFMDP is priced at $23.35, while PAVS trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas PAVS's P/E ratio is -0.05. In terms of profitability, LFMDP's ROE is -1.72%, compared to PAVS's ROE of -0.27%. Regarding short-term risk, LFMDP is less volatile compared to PAVS. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check PAVS's competition here
LFMDP vs MDVL Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, LFMDP is priced at $23.35, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas MDVL's P/E ratio is -0.05. In terms of profitability, LFMDP's ROE is -1.72%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, LFMDP is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check MDVL's competition here
LFMDP vs ATNFW Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, LFMDP is priced at $23.35, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas ATNFW's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.72%, compared to ATNFW's ROE of -2.41%. Regarding short-term risk, LFMDP is less volatile compared to ATNFW. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check ATNFW's competition here
LFMDP vs BGMSP Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, LFMDP is priced at $23.35, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, LFMDP's ROE is -1.72%, compared to BGMSP's ROE of -0.51%. Regarding short-term risk, LFMDP is less volatile compared to BGMSP. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check BGMSP's competition here
LFMDP vs BGMS Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, BGMS has a market cap of 2M. Regarding current trading prices, LFMDP is priced at $23.35, while BGMS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas BGMS's P/E ratio is -0.25. In terms of profitability, LFMDP's ROE is -1.72%, compared to BGMS's ROE of -0.51%. Regarding short-term risk, LFMDP is less volatile compared to BGMS. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check BGMS's competition here
LFMDP vs AZNH Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, LFMDP is priced at $23.35, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas AZNH's P/E ratio is 38.35. In terms of profitability, LFMDP's ROE is -1.72%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, LFMDP is less volatile compared to AZNH. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check AZNH's competition here
LFMDP vs LFLYW Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, LFMDP is priced at $23.35, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, LFMDP's ROE is -1.72%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, LFMDP and LFLYW have similar daily volatility (0.00).Check LFLYW's competition here
LFMDP vs SBFMW Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, SBFMW has a market cap of 156.2K. Regarding current trading prices, LFMDP is priced at $23.35, while SBFMW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas SBFMW's P/E ratio is -0.01. In terms of profitability, LFMDP's ROE is -1.72%, compared to SBFMW's ROE of -0.26%. Regarding short-term risk, LFMDP and SBFMW have similar daily volatility (0.00).Check SBFMW's competition here
LFMDP vs POZN Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, POZN has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.35, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas POZN's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.72%, compared to POZN's ROE of +0.61%. Regarding short-term risk, LFMDP is less volatile compared to POZN. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check POZN's competition here
LFMDP vs OREX Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, OREX has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.35, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas OREX's P/E ratio is -0.14. In terms of profitability, LFMDP's ROE is -1.72%, compared to OREX's ROE of -0.54%. Regarding short-term risk, LFMDP is less volatile compared to OREX. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check OREX's competition here
LFMDP vs CPD Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, CPD has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.35, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas CPD's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.72%, compared to CPD's ROE of N/A. Regarding short-term risk, LFMDP is less volatile compared to CPD. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check CPD's competition here
LFMDP vs SHPG Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.35, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas SHPG's P/E ratio is 11.35. In terms of profitability, LFMDP's ROE is -1.72%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, LFMDP and SHPG have similar daily volatility (0.00).Check SHPG's competition here
LFMDP vs ESRX Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.35, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas ESRX's P/E ratio is 10.69. In terms of profitability, LFMDP's ROE is -1.72%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, LFMDP and ESRX have similar daily volatility (0.00).Check ESRX's competition here
LFMDP vs IPXL Comparison July 2026
LFMDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.6M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.35, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of 287.80, whereas IPXL's P/E ratio is -10.11. In terms of profitability, LFMDP's ROE is -1.72%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, LFMDP is less volatile compared to IPXL. This indicates potentially lower risk in terms of short-term price fluctuations for LFMDP.Check IPXL's competition here